Zilia
1 known investors
Zilia develops eye-imaging technology that combines imaging, spectrometry, and artificial intelligence to detect and measure ocular biomarkers, including blood oxygen saturation, to support the prevention, diagnosis, and treatment of ocular, neurological, and systemic conditions. Its technology is aimed at health care professionals for monitoring diseases such as glaucoma, diabetic retinopathy, and age-related macular degeneration.
AI & Machine LearningDigital HealthMedical Devices
Investors · 1
Frequently asked questions
- What does Zilia do?
- Zilia develops eye-imaging technology that combines imaging, spectrometry, and artificial intelligence to detect and measure ocular biomarkers, including blood oxygen saturation, to support the prevention, diagnosis, and treatment of ocular, neurological, and systemic conditions. Its technology is aimed at health care professionals for monitoring diseases such as glaucoma, diabetic retinopathy, and age-related macular degeneration.
- Who are Zilia's investors?
- Zilia's investors include Linearis Ventures.